Related by context. Frequent words. (Click for all words.) 66 lysosomal storage disorder 63 neutropenia thrombocytopenia 62 SSc 62 HMG CoA reductase inhibitors 61 gets USFDA nod 61 diarrhea nausea vomiting 61 hypophosphatemia 61 Nausea vomiting 61 demyelinating disease 61 eosinophilia 61 Topiramate 60 Diabetic Neuropathy 60 secondary hyperparathyroidism 60 murine model 60 TTR amyloidosis 60 sensory neuropathy 60 neuroleptic malignant syndrome 60 bone marrow suppression 60 nausea constipation 60 hyperparathyroidism 59 anemias 59 efalizumab 59 connective tissue diseases 59 pancreatic insufficiency 59 coinfection 59 necrotizing 59 optic neuropathy 59 QTc prolongation 59 paroxysmal nocturnal hemoglobinuria 59 hepatotoxicity 59 pheochromocytoma 59 Losartan 58 purpura 58 Microplasmin 58 lactic acidosis 58 exocrine pancreatic insufficiency 58 lung fibrosis 58 mesylate 58 Abdominal pain 58 Eltrombopag 58 Renal impairment 58 gastrointestinal mucositis 58 fluoxetine Prozac 58 unknown etiology 58 metabolic disturbances 58 Asymptomatic 58 Pulmonary hypertension 58 Exclusion criteria 58 postherpetic neuralgia PHN 58 arthritis gout 58 fibrocystic breast disease 58 diabetes insipidus 58 Valproate 58 Candesartan 57 post herpetic neuralgia PHN 57 renal toxicity 57 hepatic failure 57 epistaxis 57 Hemorrhagic 57 Idiopathic 57 fibromyalgia syndrome 57 Gastroparesis 57 non alcoholic steatohepatitis 57 extrapyramidal symptoms 57 Zerit 57 oxcarbazepine 57 rufinamide 57 Fatty liver 57 Alzheimer Disease AD 57 Abacavir 57 postoperative ileus 57 liver dysfunction 57 candidemia 57 neurologic symptoms 57 squalamine 57 cardio renal 57 lysosomal storage diseases 57 AAT deficiency 57 nephrotoxicity 57 Dasatinib 57 Atopic dermatitis 57 inflammatory autoimmune diseases 57 coagulopathy 56 vasodilators 56 Chronic inflammation 56 Primary IGFD 56 pulmonary arterial hypertension PAH 56 parkinsonism 56 posaconazole 56 recurrent glioblastoma multiforme 56 Rhabdomyolysis 56 neurological abnormalities 56 Motavizumab 56 Angiotensin II 56 cidofovir 56 blood clotting disorder 56 Polymorphisms 56 metastatic bone 56 rheumatic disease 56 LYSTEDA 56 Epratuzumab